Adam is a Global Practice Lead and Partner at Prescient. A health economist by training, he has 25 years of global pricing and market access experience in consulting and the pharmaceutical industry, including roles at Aventis, GlaxoSmithKline and Baxter Healthcare. He is an expert in healthcare policy relating to pricing, reimbursement, and patient access to medicines for rare diseases and oncology.
Featured
Connecting Insights to Strategy
Read the article to discover leadership perspectives on how connected customer intelligence, strategic expertise and AI support better brand decisions.
News and insights
Featured
Strategy That Learns: Rethinking Brand Planning for a Changing Environment
Read the article to discover leadership perspectives on how connected customer intelligence, strategic expertise and AI support better brand decisions.
From Data-Rich to Decision-Ready
Discover why earlier, faster integration of integrated insights are a strategic imperative and now matter more than ever.
ONWARD: Driving Equitable Access and System Readiness in Cancer Care
This Dolon Institute paper highlights six interconnected barriers affecting timely access to oncology innovation, drawing on examples from healthcare systems around the world.
Careers
Work with us
If you're looking to stretch your thinking, lead with purpose, and be part of a culture that values curiosity, accountability and trust, you're in the right place.
